ALGS insider transactions
Aligos Therapeutics Inc. (ALGS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for ALGS
- SEC Form 4 filed by Officer Symons Julian A.4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Aligos Therapeutics Inc.4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Aligos Therapeutics Inc.4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Principal Accounting Officer Aneja Nikhil4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 3 filed by new insider Aneja Nikhil3 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by President and CEO Blatt Lawrence4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Officer Symons Julian A.4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Officer Calhoun Lesley Ann4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Director Nuechterlein Carole4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Director Scopa James Paul4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Director Hirth Peter4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Director Preston Heather4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Director Chavez Margarita4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Director Martell Bridget A4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by President and CEO Blatt Lawrence4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Officer Symons Julian A.4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Officer Calhoun Lesley Ann4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Achneck Hardean4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 3 filed by new insider Achneck Hardean3 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Calhoun Lesley Ann4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Blatt Lawrence4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Officer Symons Julian A.4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Director Chavez Margarita4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Director Preston Heather4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 3 filed by new insider Chavez Margarita3 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 3 filed by new insider Preston Heather3 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Director Nuechterlein Carole4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Director Hirth Peter4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Director Martell Bridget A4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Director Scopa James Paul4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Mcclure Matthew W.4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Calhoun Lesley Ann4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Symons Julian A.4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Blatt Lawrence4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Nuechterlein Carole4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Nielsen Jack4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Symons Julian A.4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Calhoun Lesley Ann4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Mcclure Matthew W.4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Scopa James Paul4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Martell Bridget A4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Blatt Lawrence4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Hirth Peter4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- New insider Roche Holding Ltd claimed ownership of 11,025,941 shares (SEC Form 3)3 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Mcclure Matthew W.4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Calhoun Lesley Ann4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Quan Lucinda Y.4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Symons Julian A.4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Blatt Lawrence4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Martell Bridget A4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Nielsen Jack4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Hirth Peter4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Scopa James Paul4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Nuechterlein Carole4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Mcclure Matthew W.4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Symons Julian A.4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Calhoun Lesley Ann4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Quan Lucinda Y.4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Beigelman Leonid4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 4 filed by Blatt Lawrence4 - Aligos Therapeutics, Inc. (0001799448) (Issuer)